CN103859374A - 一种有助于缓解视疲劳的养生保健食品配方及其制备方法 - Google Patents
一种有助于缓解视疲劳的养生保健食品配方及其制备方法 Download PDFInfo
- Publication number
- CN103859374A CN103859374A CN201210532199.3A CN201210532199A CN103859374A CN 103859374 A CN103859374 A CN 103859374A CN 201210532199 A CN201210532199 A CN 201210532199A CN 103859374 A CN103859374 A CN 103859374A
- Authority
- CN
- China
- Prior art keywords
- parts
- formula
- preparation
- health
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 18
- 208000003464 asthenopia Diseases 0.000 title claims abstract description 16
- 230000036541 health Effects 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 238000004321 preservation Methods 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 20
- 244000077923 Vaccinium vitis idaea Species 0.000 claims abstract description 12
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 11
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 11
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 11
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 11
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 claims abstract description 11
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 10
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 10
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 10
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 10
- 244000197580 Poria cocos Species 0.000 claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 9
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 9
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 9
- 240000000249 Morus alba Species 0.000 claims abstract description 7
- 208000002193 Pain Diseases 0.000 claims abstract description 7
- 206010047513 Vision blurred Diseases 0.000 claims abstract description 5
- 206010034960 Photophobia Diseases 0.000 claims abstract description 4
- 230000035807 sensation Effects 0.000 claims abstract description 4
- 210000000744 eyelid Anatomy 0.000 claims abstract description 3
- 235000016357 Mirtillo rosso Nutrition 0.000 claims description 10
- 244000241872 Lycium chinense Species 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 7
- 241000218231 Moraceae Species 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 235000004879 dioscorea Nutrition 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 4
- 206010020565 Hyperaemia Diseases 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 240000005250 Chrysanthemum indicum Species 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 244000241838 Lycium barbarum Species 0.000 abstract description 3
- 206010013774 Dry eye Diseases 0.000 abstract description 2
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 2
- 241000037831 Polygonatum sibiricum Species 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 abstract 1
- 201000005111 ocular hyperemia Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 20
- 239000003814 drug Substances 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 230000004438 eyesight Effects 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 229930014669 anthocyanidin Natural products 0.000 description 6
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 6
- 235000008758 anthocyanidins Nutrition 0.000 description 6
- 206010003549 asthenia Diseases 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 244000201986 Cassia tora Species 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 235000014552 Cassia tora Nutrition 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010049865 Achromotrichia acquired Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 241000756042 Polygonatum Species 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 244000281702 Dioscorea villosa Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000010412 Glaucoma Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003356 anti-rheumatic effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000006025 fining agent Substances 0.000 description 2
- -1 flavone compound Chemical class 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 108010052989 Naphthol AS D Esterase Proteins 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001468611 Polygonatum cyrtonema Species 0.000 description 1
- 241000037826 Polygonatum kingianum Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000009596 Tooth Mobility Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001355 anti-mycobacterial effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 210000000776 antibody secreting cell Anatomy 0.000 description 1
- 210000000628 antibody-producing cell Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 108010002060 leukoregulin Proteins 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 150000002669 lysines Chemical class 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种有助于缓解视疲劳的养生保健食品配方及其制备方法。它包括下列重量份数比的原料：枸杞子1000份、黄精1000份、茯苓1000份、山药1500份、桑葚1000份、越橘1000份、菊花700份、决明子1200份。本发明制备工艺采用传统水煎提取方法，提取物直接分装入袋，工艺简单、服用方便。本发明应用于缓解视疲劳领域，有效改善眼干涩、异物感、眼皮沉重感、视物模糊、畏光流泪、眼胀痛及眼部充血等症状。
Description
技术领域
本发明公开了一种有助于缓解视疲劳的养生保健食品配方及其制备方法。
背景技术
现代生活方式的改变和社会的进步，使得眼睛的负担越来越大，长时间伏案，近距离工作，过度使用眼的调节能力，都在加重视疲劳，长期用眼者，应高度重视眼保健。祖国传统中医药在缓解视疲劳方面具有很大优势。
发明内容
本发明的目的是提供一种有助于缓解视疲劳的养生保健食品配方及其制备方法。
本发明是由下述重量份数的原料制成的：枸杞子600-1400份、黄精600-1500份、茯苓600-1500份、山药1000-2000份、桑椹800-1300份、越橘600-1400份、菊花400-1100份、决明子900-1500份。
以上各成分的最佳重量配比是：枸杞子1000份、黄精1000份、茯苓1000份、山药1500份、桑葚1000份、越橘1000份、菊花700份、决明子1200份。
一、本发明制备方法包括以下步骤：
(1)将配方中各原料置于煮提锅中，浸润30分钟，然后加入10倍量的去离子水，室温浸泡2小时后加热至沸腾，煮沸提取2小时，倾出水提液，过滤。
(2)再次加入原料10倍量的去离子水，煮沸提取2小时，倾出水提液，过滤。
(3)合并步骤(1)、(2)所得滤液，冷却至室温，离心30分钟，弃去沉淀，收集上清液。
(4)将步骤(3)所得的滤液浓缩至药液比为1∶2(60℃)，添加天然吸附澄清剂(北京正天成澄清技术有限公司)，离心30分钟，弃去沉淀，收集上清液；
(5)将步骤(4)所得的上清液浓缩至相对密度≥1.27g·ml-1(60℃)，干燥，粉碎，分装成10克的小包装。
本发明的配方组成合理，制作工艺科学，携带及食用方便。长期食用本品能有效缓解视疲劳，改善眼干涩、异物感、眼皮沉重感、视物模糊、畏光流泪、眼胀痛及眼部充血等症状。
二、用药分析
枸杞子为茄科植物宁夏枸杞Lycium barbarum L.的干燥成熟果实。
【性味与归经】甘、平。归肝、肾经。
【功效】滋补肝肾，益精明目。
【应用】治疗精血不足所致的视力减退、内障目昏、头晕目眩、腰膝酸软、遗精滑泄、耳聋、牙齿松动、须发早白、失眠多梦以及肝肾阴虚，潮热盗汗、消渴等证。
《神农本草经》称枸杞子“久服坚筋骨，轻身不老，耐寒暑”。
《本草汇言》赞之“使气可充，血可补，阳可生，阴可长”。
《本草纲目》记载：“枸杞，补肾生精，养肝，明目，坚筋骨，去疲劳，易颜色，变白，明目安神，令人长寿。”
现代医学研究证实：枸杞子含有甜菜硷、多糖、粗脂肪、粗蛋白、胡萝卜素、维生素A、维生素C、维生素B1、维生素B2及钙、磷、铁、锌、锰、亚油酸等营养成分。枸杞子对免疫有促进作用，同时具有免疫调节作用；可提高血睾酮水平，起强壮作用；对造血功能有促进作用；对正常健康人也有显著升白细胞作用；还有抗氧化、抗衰老、抗疲劳、抗突变、抗肿瘤、降血脂、保肝及抗脂肪肝、降血糖、降血压、补肾、明目、养颜、健脑、排毒、保护生殖系统、抗辐射损伤等功能。
黄精为百合科植物滇黄精(Polygonatum kingianum Coll.et Hemsl.)、黄精(Polygonatumsibiricum Red.)或多花黄精(Polygonatum cyrtonema Hua.)的干燥根茎。
【性味与归经】甘、平。归脾、肺、肾经。
【功效】补气养阴，健脾，润肺，益肾。
【应用】治疗肺金气阴两伤之干咳少痰、肺肾阴虚之劳嗽久咳、脾胃虚弱、体倦乏力、食欲不振、口干食少，能延缓衰老，改善头晕、腰膝酸软、须发早白、精血不足，内热消渴等症。
《本草纲目》：“补诸虚、止寒热、填精髓。”
《日华子本草》：“补五劳七伤，助筋骨，生肌，耐寒暑，益脾胃，润心肺”。
现代医学研究证实：黄精根茎含烟酸、粘液质、醌类，并含黄精多糖甲、乙、丙，黄精低聚糖甲、乙、丙，多糖甲、乙、丙均由葡萄糖、甘露糖、半乳糖醛酸结合而成；低聚糖甲、乙、丙均由葡萄糖和果糖结合而成，另含赖氨酸等11种氨基酸。能提高机体免疫功能和促进DNA、RNA及蛋白质的合成，促进淋巴细胞转化作用；具有显著的抗结核杆菌作用；对多种致病性真菌有抑制作用；对伤寒杆菌、金黄色葡萄球菌也有抑制作用；有增加冠脉流量及降压作用，并能降血脂及减轻冠状动脉粥样硬化程度；对肾上腺素引起的血糖过高呈显著抑制作用；还有抑制肾上腺皮质的作用和延缓衰老作用；黄精多糖具有免疫激活作用。
茯苓为多孔菌科真菌茯苓Poria cocos(Schw.)Wolf的干燥菌核。
【性味与归经】甘、淡，平。归心、肺、脾、肾经。
【功效】利水渗湿，健脾宁心。
【应用】用于水肿尿少，痰饮眩悸，脾虚食少，便溏泄泻，心神不安，惊悸失眠。
《日华子本草》：“补五劳七伤，安胎，暖腰膝，开心益智，止健忘。”
《用药心法》：“茯苓，淡能利窍，甘以助阳，除湿之圣药也。味甘平补阳，益脾逐水，生津导气。”
现代医学研究证实：茯苓能增强机体免疫功能，茯苓多糖具有抗胸腺萎缩及抗脾脏增大和抑制肿瘤生长的功能，茯苓多糖灌胃能增强小鼠巨噬细胞吞噬功能，增加ANAE阳性淋巴细胞数，还能使小鼠脾脏抗体分泌细胞数明显增多。茯苓多糖亦能使环磷酰胺所引起的大白鼠白细胞减少加速回升。羧甲基茯苓多糖还有免疫调节、保肝降酶、间接抗病毒、诱生和促诱生干扰素、减轻放射副反应，诱生和促诱生白细胞调节素等多种生理活性。
山药为薯蓣科植物薯蓣Dioscorea opposite Thumb.的干燥根茎。
【性味与归经】甘，平。归肺、脾、肾经。
【功效】补脾养胃，生津益肺，补肾涩精。
【应用】山药味甘性平，作用缓和，不寒不热，既能补气，又能养阴，补而不滞，滋而不腻。乃平补肺脾肾之佳品。多用于消瘦乏力、食少、便溏者，如《本草纲目》云：“益肾气，健脾胃。”因其含有较多的营养成分，又容易消化吸收，可作为食品长期使用。《神农本草经》云其“补中，益气力，长肌肉”，故对于慢性病或病后虚弱，需营养调补而脾运不健者，则是佳品，如薏米山药粥。
现代医学研究证实：山药的主要成分为淀粉酶，能刺激胃肠道运动，促进肠内物排空，增加小肠吸收功能，有助于消化，降压，降糖，防治心血管疾病。山药的提纯淀粉能降低类脂浓度，同时降低主动脉和心脏的糖的浓度及胆固醇的浓度。山药富含多糖，可刺激和调节免疫系统，能增加血液白细胞含量，加强白细胞的吞噬作用，因此山药可作为人们增加免疫能力的保健药。山药中含有蛋白质(包括人体所需要的16种氨基酸)、糖类、维生素类等有效成分，具有较好的延缓衰老的作用，显著延长生命，经常食用山药，有益健康。
桑椹为桑科植物桑Morus alba L.的干燥果穗。
【性味与归经】甘、酸，寒。归肝、肾经。
【功效】滋阴补血，生津润燥。
【应用】适用于眩晕耳鸣、心悸失眠、须发早白、津伤口渴、内热消渴、血虚便秘、目暗，耳鸣、瘰疬、关节不利。
《滇南本草》：“益肾脏而固精，久服黑发明目。”
《随息隐居食谱》：“滋肝肾，充血液，祛风湿，健步履，息虚风，清虚火。”
《本草拾遗》：“利五脏关节，通血气。久服不饥，安魂镇神，令人聪明，变白不老。”
现代医学研究证实：桑椹含糖、鞣酸、苹果酸及维生素B1、B2，C和胡萝卜素。桑椹油的脂肪酸主要由亚油酸和硬脂酸、油酸等组成。有改善皮肤(包括头皮)血液供应，营养肌肤，使皮肤白嫩及乌发等作用，并能延缓衰老，是健体美颜、抗衰老的佳果与良药。常食桑椹可以明目，缓解眼睛疲劳干涩的症状。桑葚具有免疫促进作用，对脾脏有增重作用，对溶血性反应有增强作用，可防止人体动脉硬化、骨骼关节硬化，促进新陈代谢。它可以促进血红细胞的生长，防止白细胞减少，并对治疗糖尿病、贫血、高血压、高血脂、冠心病、神经衰弱等病症具有辅助功效。适量食用能促进胃液分泌，刺激肠蠕动及解除燥热。
越橘为杜鹃花科乌饭树属植物Vaccinium myrtillus L.越橘的果实。
现代医学研究证实：越橘富含花青素，在越橘中发现超过15种不同的花青素。花青素可有助于维持毛细血管完整性和稳定胶原质。花青素也是有力的抗氧化剂。众多的临床研究显示越橘在治疗循环系统不适、静脉曲张和其它静脉和动脉不适方面十分有效。
花青素可稳定内皮细胞中磷脂，通过增加胶原质及黏多糖维持动脉壁结构的完整性，以此通过合成物来保护静脉和动脉。花青素同样防止血小板在内皮细胞表面的聚集和粘着。研究还显示越橘可通过刺激视紫质产生来起到在亚铁血红素所致和糖尿病导致视网膜病变中协作治疗的作用。
菊花为菊科植物菊Chrysanthemum morifolium Ramat.的干燥头状花序。
【性味与归经】甘、苦，微寒。归肺、肝经。
【功效】散风清热，平肝明目，清热解毒。
【应用】用于风热感冒，头痛眩晕，目赤肿痛，眼目昏花，疮痈肿毒。
现代医学研究证实：菊花的化学成分比较复杂，其中黄酮类化合物、三萜类化合物和挥发油是其主要有效成分。菊花具有治疗冠心病、降低血压、预防高血脂、抗菌、抗病毒、抗炎、抗衰老等多种药理活性。
决明子为豆科植物决明Cassia obtuse folia L.或小决明Cassia tora L.的干燥成熟种子。
【性味与归经】甘、苦、咸，微寒。归肝、大肠经。
【功效】清热明目，润肠通便。
【应用】用于目赤涩痛，羞明多泪，头痛眩晕，目暗不明，大便秘结。
《本经》：治青盲，目淫肤赤白膜，眼赤痛，泪出，久服益精光。
《别录》：疗唇口青。
《药性论》：利五脏，除肝家热。
《日华子本草》：助肝气，益精水；调末涂，消肿毒，熁太阳穴治头痛，又贴脑心止鼻衄；作枕胜黑豆，治头风，明目。
现代医学研究证实：决明子含有多种维生素和丰富的氨基酸、脂肪、碳水化合物等，具有清肝火、祛风湿、益肾明目等功能，常饮决明子茶，可使血压正常，大便通畅，老眼不花。临床实验证明，喝决明子茶可以清肝明目、防止视力模糊、降血压、降血脂、减少胆固醇等，对于防治冠心病、高血压都有不错的疗效；而且决明子富含维生素A及锌，可防治夜盲症以及避免小儿缺锌。此外，决明子茶润肠通便的功能也能解决现代人肠胃及便秘的问题，可以治疗大便燥结，帮助顺利排便。
具体实施方式
实施例1提取物及产品的制备
按最佳重量配比称取枸杞子1000份、黄精1000份、茯苓1000份、山药1500份、桑葚1000份、越橘1000份、菊花700份、决明子1200份。加10倍量去离子水煮提2次，每次2小时，煮提液过滤、离心(3000转/分)30分钟，取上清液，浓缩至药液比1∶2(60℃)，后加入天然吸附澄清剂(4％澄清剂A，8％澄清剂B)，然后离心(3000转/分)30分钟，取上清液继续浓缩至相对密度≥1.27g·ml-1(60℃)后，带式干燥，粉碎成细粉，分装成10克左右的小包装。
实施例2产品用于缓解视疲劳
个案报道
王××，女，28岁，办公室职员。自述由于工作性质，每日长时间坐于电脑前，近距离看电脑8小时以上，经常感觉眼睛干燥、刺痛、视物不清楚、严重时感觉头痛、头昏、恶心、精神萎靡、注意力不集中、记忆力下降、食欲不振、以及颈肩腰背酸痛和指关节麻木等。服食本发明产品每日2袋，连续30天后，自我感觉眼睛不再像以前那样干燥，刺痛感、头痛、头昏、恶心、精神萎靡等症状减轻或消失。
Claims (4)
1.一种有助于缓解视疲劳的养生保健食品配方，其特征在于所用的原料及其重量份数：枸杞子600-1400份、黄精600-1500份、茯苓600-1500份、山药1000-2000份、桑椹800-1300份、越橘600-1400份、菊花400-1100份、决明子900-1500份。
2.根据权利要求1所述的一种有助于缓解视疲劳的养生保健食品配方，其特征在于所用的原料及其最佳重量配比：枸杞子1000份、黄精1000份、茯苓1000份、山药1500份、桑葚1000份、越橘1000份、菊花700份、决明子1200份。
3.根据权利要求1或2所述的一种有助于缓解视疲劳的养生保健食品配方及其制备方法，其特征在于制备过程按以下步骤进行：
(1)将配方中各原料置于煮提锅中，浸润30分钟，然后加入10倍量的去离子水，室温浸泡2小时；然后加热至沸腾，煮沸提取2小时，倾出水提液，过滤；
(2)再次加入原料10倍量的去离子水，煮沸提取2小时，倾出水提液，过滤；
(3)合并步骤(1)、(2)所得滤液，冷却，离心，弃去沉淀，收集上清液；
(4)将步骤(3)所得的滤液浓缩，添加天然吸附澄清剂，弃去沉淀，收集上清液；
(5)将步骤(4)所得的上清液浓缩，干燥，粉碎，分装成10克的小包装。
4.根据权利要求1或2所述的一种有助于缓解视疲劳的养生保健食品配方，其特征在于：本发明用于缓解视疲劳，改善眼干涩、异物感、眼皮沉重感、视物模糊、畏光流泪、眼胀痛及眼部充血等症状。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210532199.3A CN103859374A (zh) | 2012-12-10 | 2012-12-10 | 一种有助于缓解视疲劳的养生保健食品配方及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210532199.3A CN103859374A (zh) | 2012-12-10 | 2012-12-10 | 一种有助于缓解视疲劳的养生保健食品配方及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103859374A true CN103859374A (zh) | 2014-06-18 |
Family
ID=50898832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210532199.3A Pending CN103859374A (zh) | 2012-12-10 | 2012-12-10 | 一种有助于缓解视疲劳的养生保健食品配方及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103859374A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106689960A (zh) * | 2017-01-11 | 2017-05-24 | 珠海市御得养生食品研究院有限公司 | 一种保护视力固体饮料 |
| CN107625123A (zh) * | 2017-09-29 | 2018-01-26 | 云南省农业科学院高山经济植物研究所 | 一种护视明目制剂及其制备方法 |
| CN110269165A (zh) * | 2019-06-11 | 2019-09-24 | 尚赫（天津）科技开发有限公司 | 护眼饮料及其制备工艺 |
| CN116172198A (zh) * | 2022-07-23 | 2023-05-30 | 北京光信商贸有限公司 | 一种中草药保健饮料及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101248878A (zh) * | 2008-03-28 | 2008-08-27 | 孙景波 | 营养视神经的保健食品及其制备方法 |
| JP2011087919A (ja) * | 2010-09-06 | 2011-05-06 | Kao Corp | 新規体質診断方法およびそれを用いたカウンセリング方法 |
-
2012
- 2012-12-10 CN CN201210532199.3A patent/CN103859374A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101248878A (zh) * | 2008-03-28 | 2008-08-27 | 孙景波 | 营养视神经的保健食品及其制备方法 |
| JP2011087919A (ja) * | 2010-09-06 | 2011-05-06 | Kao Corp | 新規体質診断方法およびそれを用いたカウンセリング方法 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106689960A (zh) * | 2017-01-11 | 2017-05-24 | 珠海市御得养生食品研究院有限公司 | 一种保护视力固体饮料 |
| CN107625123A (zh) * | 2017-09-29 | 2018-01-26 | 云南省农业科学院高山经济植物研究所 | 一种护视明目制剂及其制备方法 |
| CN110269165A (zh) * | 2019-06-11 | 2019-09-24 | 尚赫（天津）科技开发有限公司 | 护眼饮料及其制备工艺 |
| CN116172198A (zh) * | 2022-07-23 | 2023-05-30 | 北京光信商贸有限公司 | 一种中草药保健饮料及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100512676C (zh) | 一种具有保健作用的调味料 | |
| CN102784295B (zh) | 一种改善女性更年期综合症的保健制剂配方及其制备方法 | |
| CN103859378A (zh) | 一种有助于降低血糖的养生保健食品配方及其制备方法 | |
| CN102823653A (zh) | 系列复方保健药膳奶片及其制备方法 | |
| CN104186777A (zh) | 一种保健功能茶及其制备方法 | |
| CN102640822B (zh) | 一种保健茶膏及其制备方法 | |
| CN106266700A (zh) | 一种沙棘组方袋泡型茶剂调配及制作方法 | |
| CN103689563A (zh) | 一种有助于改善睡眠的养生保健食品配方及其制备方法 | |
| CN103859375A (zh) | 一种有助于增强免疫力的养生保健食品配方及其制备方法 | |
| CN103859379A (zh) | 一种有助于改善记忆的养生保健食品配方及其制备方法 | |
| CN103859369A (zh) | 一种有助于美胸丰胸的养生保健食品配方及其制备方法 | |
| CN106860680A (zh) | 金花人参压片糖果及其制备方法 | |
| CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
| CN103652926A (zh) | 肿瘤病人食品组合物 | |
| CN102940219B (zh) | 一种土豆饼及其制作方法 | |
| CN103859374A (zh) | 一种有助于缓解视疲劳的养生保健食品配方及其制备方法 | |
| CN108497474A (zh) | 一种全植物药食糊 | |
| CN1698875A (zh) | 一种治疗癌症的药酒 | |
| CN105685317A (zh) | 富含硒火麻茶及其制备方法 | |
| CN103689562A (zh) | 一种有助于缓解疲劳的养生保健食品配方及其制备方法 | |
| CN107950862A (zh) | 一种红枣羹及其制作方法 | |
| CN1742970A (zh) | 佛手片及其制备工艺 | |
| CN103340919B (zh) | 一种灵芝精粉复方软胶囊及其制备方法 | |
| CN102113562A (zh) | 无花果黑芝麻生发乌发果珍及其制备方法 | |
| CN109527577A (zh) | 一种具有解酒护肝功能的组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140618 |